Haematologica
(May 2024)
Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia
- Rima S. Zahr,
- Sara R. Rashkin,
- Maria Armila Ruiz,
- Laila Elsherif,
- Guohui Ren,
- Guadalupe Salas,
- Kenneth I. Ataga,
- Victor R. Gordeuk,
- Jeffrey Lebensburger,
- Xu Zhang,
- Santosh L. Saraf
Affiliations
- Rima S. Zahr
- Division of Pediatric Nephrology and Hypertension, University of Tennessee Health Science Center Memphis, TN
- Sara R. Rashkin
- Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN
- Maria Armila Ruiz
- Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
- Laila Elsherif
- Center for Sickle Cell Disease, University of Tennessee Health Sciences Center, Memphis, TN
- Guohui Ren
- Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
- Guadalupe Salas
- Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
- Kenneth I. Ataga
- Center for Sickle Cell Disease, University of Tennessee Health Sciences Center, Memphis, TN
- Victor R. Gordeuk
- Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
- Jeffrey Lebensburger
- Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
- Xu Zhang
- Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
- Santosh L. Saraf
- Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
- DOI
-
https://doi.org/10.3324/haematol.2023.284920
- Journal volume & issue
-
Vol. 999,
no. 1
WeChat QR code
